| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,546 |
1,242 |
$376K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,835 |
1,488 |
$322K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,533 |
2,128 |
$298K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,390 |
1,314 |
$221K |
| 80050 |
General health panel |
1,617 |
1,268 |
$186K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,914 |
4,178 |
$89K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
284 |
231 |
$87K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
726 |
546 |
$66K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,115 |
800 |
$64K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,390 |
517 |
$63K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
726 |
658 |
$57K |
| 36415 |
Collection of venous blood by venipuncture |
4,331 |
3,146 |
$43K |
| 80053 |
Comprehensive metabolic panel |
1,340 |
1,009 |
$41K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
632 |
448 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
378 |
358 |
$36K |
| J3490 |
Unclassified drugs |
1,426 |
836 |
$34K |
| 81001 |
|
1,930 |
1,675 |
$32K |
| 84484 |
|
469 |
372 |
$31K |
| 71045 |
Radiologic examination, chest; single view |
370 |
313 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,476 |
1,125 |
$27K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
4,469 |
1,191 |
$23K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
236 |
77 |
$21K |
| 86140 |
|
480 |
395 |
$18K |
| G0378 |
Hospital observation service, per hour |
30 |
29 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
26 |
24 |
$15K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
919 |
826 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
374 |
280 |
$14K |
| 84145 |
|
230 |
179 |
$13K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
590 |
509 |
$11K |
| 83690 |
|
256 |
198 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
439 |
328 |
$10K |
| 85027 |
|
541 |
416 |
$9K |
| 97161 |
|
260 |
236 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
317 |
202 |
$7K |
| 83880 |
|
79 |
68 |
$6K |
| 82150 |
|
187 |
146 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
123 |
118 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
406 |
363 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
228 |
183 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
131 |
116 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
32 |
26 |
$2K |
| 85379 |
|
25 |
25 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
12 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
44 |
39 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13 |
12 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
12 |
$897.45 |
| 81025 |
|
17 |
15 |
$764.40 |
| A4657 |
Syringe, with or without needle, each |
15 |
12 |
$756.22 |
| 87807 |
|
12 |
12 |
$664.56 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
42 |
40 |
$485.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$461.76 |
| 87210 |
|
12 |
12 |
$410.28 |
| 83605 |
|
17 |
13 |
$381.47 |
| 87077 |
|
12 |
12 |
$342.37 |
| 82550 |
|
19 |
15 |
$327.57 |
| 82553 |
|
17 |
13 |
$318.99 |
| 81015 |
|
12 |
12 |
$266.76 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$0.00 |